
Designing self-destructing bacteria make effective tuberculosis vaccines: Study
Hindustan TimesWorking towards more effective tuberculosis vaccinations, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with "kill switches" that may be activated to stop the bacteria after they elicit an immune response. "BCG protects children from tuberculosis meningitis, but it doesn't effectively protect adults from pulmonary tuberculosis, which is why it's only used in high-incidence countries," said Dr. Dirk Schnappinger, professor of microbiology and immunology at Weill Cornell Medicine and a senior author on both of the new studies. "We needed a version of BCG that triggers an immune response, but then you can flip a switch to eliminate the bacteria," said Dr. Schnappinger. Chan School of Public Health, the team's second paper is an effort to make clinical trials feasible--developing extremely safe strains of TB bacteria that can be used in controlled human infection studies.
History of this topic

TB: gene editing could add new power to a 100-year-old vaccine
The Hindu
Tuberculosis tricks body's immune system to make people infectious, claims study
India TV News
New vaccines for old foe
The HinduDiscover Related











































